Cello Health PLC Result of AGM (5327N)
May 09 2018 - 7:14AM
UK Regulatory
TIDMCLL
RNS Number : 5327N
Cello Health PLC
09 May 2018
FOR IMMEDIATE RELEASE 9 May 2018
Cello Health plc
Result of AGM
At the Annual General Meeting of Cello Health plc (AIM:CLL) held
today, all the resolutions put to shareholders were duly
passed.
Enquiries:
Cello Health plc 020 7812 8460
Mark Scott, Chief Executive
Mark Bentley, Group Finance
Director
Cenkos Securities plc
Mark Connelly/Harry Hargreaves 020 7397 8900
Buchanan
Mark Court 020 7466 5000
Jamie Hooper
Sophie Wills
About Cello Health plc
We are a global healthcare-focused advisory Group comprised of a
set of leading clinical, commercial advisory and digital delivery
capabilities. We currently service 24 of the top 25 pharmaceutical
clients globally as well as a wide range of biotech, diagnostics,
devices and other key non-healthcare clients.
We enable clients to differentiate their propositions and drive
brand success in ever more complex global markets. We deliver our
services through nearly 1,000 highly skilled professionals
utilising latest thinking, technology and digital solutions.
Cello Health plc delivers its services from an office network in
the UK, USA, and Asia, with hub offices in New York, Philadelphia,
London, Edinburgh, Farnham and Cheltenham.
For further information, please visit:
https://cellohealthplc.com/
This information is provided by RNS
The company news service from the London Stock Exchange
END
RAGEAASNEFAPEFF
(END) Dow Jones Newswires
May 09, 2018 08:14 ET (12:14 GMT)
Cello Health (LSE:CLL)
Historical Stock Chart
From Apr 2024 to May 2024
Cello Health (LSE:CLL)
Historical Stock Chart
From May 2023 to May 2024
Real-Time news about Cello Health Plc (London Stock Exchange): 0 recent articles
More Cello Health News Articles